###begin article-title 0
###xml 34 55 34 55 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 34 55 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 78 84 <span type="species:ncbi:9606">Humans</span>
Key Role for Clumping Factor B in Staphylococcus aureus Nasal Colonization of Humans
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 0 21 0 21 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 175 184 175 184 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 175 184 <span type="species:ncbi:1280">S. aureus</span>
Staphylococcus aureus permanently colonizes the vestibulum nasi of one-fifth of the human population, which is a risk factor for autoinfection. The precise mechanisms whereby S. aureus colonizes the nose are still unknown. The staphylococcal cell-wall protein clumping factor B (ClfB) promotes adhesion to squamous epithelial cells in vitro and might be a physiologically relevant colonization factor.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB</italic>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 701 702 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
We define the role of the staphylococcal cytokeratin-binding protein ClfB in the colonization process by artificial inoculation of human volunteers with a wild-type strain and its single locus ClfB knock-out mutant. The wild-type strain adhered to immobilized recombinant human cytokeratin 10 (CK10) in a dose-dependent manner, whereas the ClfB- mutant did not. The wild-type strain, when grown to the stationary phase in a poor growth medium, adhered better to CK10, than when the same strain was grown in a nutrient-rich environment. Nasal cultures show that the mutant strain is eliminated from the nares significantly faster than the wild-type strain, with a median of 3 +/- 1 d versus 7 +/- 4 d (p = 0.006). Furthermore, the wild-type strain was still present in the nares of 3/16 volunteers at the end of follow-up, and the mutant strain was not.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 136 145 136 145 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 136 145 <span type="species:ncbi:1280">S. aureus</span>
The human colonization model, in combination with in vitro data, shows that the ClfB protein is a major determinant of nasal-persistent S. aureus carriage and is a candidate target molecule for decolonization strategies.
###end p 6
###begin p 7
###xml 54 75 54 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 190 195 <span type="species:ncbi:9606">human</span>
Heiman Wertheim and colleagues investigate the role ofStaphylococcus aureus clumping factor B, a cell wall protein, in bacterial adherence to epithelial cells and persistent colonization of human nostrils.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 0 21 0 21 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 579 588 579 588 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 658 667 658 667 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 579 588 <span type="species:ncbi:1280">S. aureus</span>
###xml 613 620 <span type="species:ncbi:9606">patient</span>
###xml 658 667 <span type="species:ncbi:1280">S. aureus</span>
Staphylococcus aureus are common bacteria that normally live on the skin. They also colonize the nostrils of about one in five adults permanently and another one in three adults intermittently. Although these bacteria usually coexist peacefully with their human carriers, they can cause minor infections such as pimples and boils if they enter the skin through a cut or a sore. They can also cause potentially life-threatening infections such as blood poisoning and pneumonia. These serious, invasive infections are often "autoinfections." That is, they are caused by strains of S. aureus that are present in the patient's nose before they become ill. Minor S. aureus infections can be treated without antibiotics-by draining a boil, for example. Invasive infections are usually treated with antibiotics such as flucloxacillin.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 38 47 38 47 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 212 221 212 221 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 458 467 458 467 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 537 546 537 546 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 641 650 641 650 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 1066 1075 1066 1075 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 1239 1248 1239 1248 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 38 47 <span type="species:ncbi:1280">S. aureus</span>
###xml 212 221 <span type="species:ncbi:1280">S. aureus</span>
###xml 223 227 <span type="species:ncbi:1280">MRSA</span>
###xml 268 274 <span type="species:ncbi:9606">people</span>
###xml 354 358 <span type="species:ncbi:1280">MRSA</span>
###xml 394 400 <span type="species:ncbi:9606">people</span>
###xml 458 467 <span type="species:ncbi:1280">S. aureus</span>
###xml 537 546 <span type="species:ncbi:1280">S. aureus</span>
###xml 641 650 <span type="species:ncbi:1280">S. aureus</span>
###xml 922 927 <span type="species:ncbi:9606">human</span>
###xml 1066 1075 <span type="species:ncbi:1280">S. aureus</span>
###xml 1083 1088 <span type="species:ncbi:9606">human</span>
###xml 1165 1170 <span type="species:ncbi:9606">human</span>
###xml 1224 1229 <span type="species:ncbi:10090">mouse</span>
###xml 1239 1248 <span type="species:ncbi:1280">S. aureus</span>
There is no effective vaccine against S. aureus infections and these bacteria are becoming increasingly resistant to flucloxacillin, methicillin, and other antibiotics. Worryingly, although methicillin-resistant S. aureus (MRSA) infections occur most frequently among people in health-care facilities who have weakened immune systems, community-acquired MRSA infections among otherwise healthy people are increasingly common. Consequently, new ways to avoid S. aureus infections are urgently needed. Because persistent nasal carriers of S. aureus have an increased risk of infection, one strategy might be to prevent nasal colonization with S. aureus. How these bacteria colonize the nose is poorly understood, but is likely to involve interactions between molecules expressed on the surface of the bacteria and molecules expressed on the surface of the cells lining the nostrils. In this study, the researchers use a new human nasal colonization assay to investigate the involvement of a bacterial surface protein called clumping factor B (ClfB) in the survival of S. aureus in the human nose. ClfB binds to cytokeratin 10, a protein expressed by cells lining the human nose, and has been implicated in the colonization of mouse noses by S. aureus.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 39 48 39 48 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 241 250 241 250 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 408 417 408 417 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 39 48 <span type="species:ncbi:1280">S. aureus</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 241 250 <span type="species:ncbi:1280">S. aureus</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 408 417 <span type="species:ncbi:1280">S. aureus</span>
###xml 525 530 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
###xml 976 981 <span type="species:ncbi:9606">human</span>
###xml 1225 1230 <span type="species:ncbi:9606">human</span>
The researchers introduced a strain of S. aureus that made ClfB and an otherwise identical, mutant strain that lacked ClfB into the nostrils of healthy human volunteers and measured how long the two strains survived. For safety reasons, the S. aureus strains used in this study have an additional defect that makes them less likely to colonize and persist in the human nose than the strains found in natural S. aureus carriers. Although both strains grew equally well in the laboratory, the mutant strain was eliminated from human noses much quicker than the strain that made ClfB. Mutant bacteria lacking ClfB were cleared from the nostrils of all the volunteers within two weeks, whereas the bacteria that made ClfB were still present in some of the volunteers four weeks after their introduction. When the researchers investigated how well the two strains stuck to a layer of human cytokeratin 10 in a plastic dish, they found that the bacteria that made ClfB stuck to the human protein but the mutant bacteria did not. Furthermore, the strain with ClfB stuck particularly well to cytokeratin 10 when the bacteria had been grown in conditions where nutrients were limiting, a situation that mimics bacterial growth in the human nose.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 105 114 105 114 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 159 168 159 168 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 275 284 275 284 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 527 536 527 536 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 105 114 <span type="species:ncbi:1280">S. aureus</span>
###xml 159 168 <span type="species:ncbi:1280">S. aureus</span>
###xml 247 252 <span type="species:ncbi:9606">human</span>
###xml 275 284 <span type="species:ncbi:1280">S. aureus</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 527 536 <span type="species:ncbi:1280">S. aureus</span>
These findings show that ClfB is an important factor in the establishment of human nasal colonization by S. aureus and suggest that ClfB might be a target for S. aureus decolonization strategies. Furthermore, although ClfB is clearly important in human nasal colonization by S. aureus, it is likely that additional bacterial factors will also be involved in this process. The human nasal colonization model used in this study may be useful in the identification of these additional factors and also as a test bed for potential S. aureus decolonization strategies.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
The MedlinePlus encyclopedia has a page on  (in English and Spanish)
###end p 19
###begin p 20
The US Centers for Disease Control and Prevention provides information on  (in English and Spanish)
###end p 20
###begin p 21
The UK National Health Service's health website (NHS Direct) provides information about  and about 
###end p 21
###begin p 22
###xml 31 52 31 52 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 31 52 <span type="species:ncbi:1280">Staphylococcus aureus</span>
The provides information about Staphylococcus aureus
###end p 22
###begin title 23
Introduction
###end title 23
###begin p 24
###xml 0 21 0 21 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 319 328 319 328 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 430 439 430 439 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b001">1</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b002">2</xref>
###xml 503 512 503 512 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b003">3</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b004">4</xref>
###xml 683 692 683 692 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b005">5</xref>
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 319 328 <span type="species:ncbi:1280">S. aureus</span>
###xml 430 439 <span type="species:ncbi:1280">S. aureus</span>
###xml 441 445 <span type="species:ncbi:1280">MRSA</span>
###xml 503 512 <span type="species:ncbi:1280">S. aureus</span>
###xml 607 614 <span type="species:ncbi:9606">patient</span>
###xml 683 692 <span type="species:ncbi:1280">S. aureus</span>
Staphylococcus aureus remains one of the prime human bacterial pathogens, associated with significant morbidity and mortality worldwide. The combination of an increasing number of antimicrobials to which this pathogen has become resistant and the lack of an effective vaccine underscores that alternatives to combating S. aureus disease are urgently required. In addition, community-acquired infections with methicillin-resistant S. aureus (MRSA) are rising steeply [1,2]. Approximately 80% of invasive S. aureus infections are autologous [3,4] in that they are caused by strains carried in the nose by the patient prior to illness. Approximately 20% of the adult population carries S. aureus in their nose persistently, another 30% intermittently, whereas 50% are non-carriers [5].
###end p 24
###begin p 25
###xml 29 38 29 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 145 154 145 154 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 245 254 245 254 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b006">6</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b007">7</xref>
###xml 29 38 <span type="species:ncbi:1280">S. aureus</span>
###xml 145 154 <span type="species:ncbi:1280">S. aureus</span>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 245 254 <span type="species:ncbi:1280">S. aureus</span>
###xml 309 314 <span type="species:ncbi:9606">human</span>
Persistent nasal carriers of S. aureus have an increased risk of infection. Therefore, discovering strategies that prevent nasal colonization of S. aureus in patients at risk of (auto)infection is attracting increasing attention. Intervening in S. aureus colonization, however, requires the identification of human and bacterial factors that are important in the process [6,7].
###end p 25
###begin p 26
###xml 22 31 22 31 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b008">8</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b009">9</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b010">10</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b011">11</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b012">12</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b013">13</xref>
###xml 22 31 <span type="species:ncbi:1280">S. aureus</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
Nasal colonization by S. aureus is likely to be facilitated by its surface structures. These range from peptidoglycan molecules and cell-wall teichoic acids to a wide variety of proteins belonging to the family of microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) [8,9]. The MSCRAMM clumping factor B (ClfB) was recently identified as a major determinant of nasal colonization of the mouse [10,11]. ClfB binds to human-type I cytokeratin 10 (CK10), which is expressed on squamous epithelial cells [12]. In addition, it was shown that anti-ClfB antibodies could actively and passively protect mice from staphylococcal colonization in the nose [13].
###end p 26
###begin p 27
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b006">6</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b014">14</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b015">15</xref>
###xml 292 301 292 301 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b016">16</xref>
###xml 562 571 562 571 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 182 187 <span type="species:ncbi:9606">human</span>
###xml 292 301 <span type="species:ncbi:1280">S. aureus</span>
###xml 460 466 <span type="species:ncbi:9606">humans</span>
###xml 562 571 <span type="species:ncbi:1280">S. aureus</span>
###xml 594 600 <span type="species:ncbi:9606">humans</span>
However, experiments to prove causal involvement of bacterial factors in maintaining the colonized state were performed in vitro or in animal models of questionable relevance to the human situation [6,14,15]. None of the animal species used in model experiments are natural nasal carriers of S. aureus. Other studies relied on indirect clinical or microbiological observations to define the involvement of bacterial determinants in colonization and disease in humans [16]. To our knowledge, in vivo experiments on the relevance of bacterial factors required for S. aureus nasal colonization in humans have not been performed thus far.
###end p 27
###begin p 28
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b017">17</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b018">18</xref>
###xml 395 404 395 404 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b019">19</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b021">21</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 395 404 <span type="species:ncbi:1280">S. aureus</span>
Although animal models may help define the molecular mechanisms leading to colonization of the nose, a human model of colonization will probably be most appropriate [17,18]. Such an experimental model is essential in the design of new strategies to prevent infection. This is important since recent trials with topical antibiotics showed little to no preventive effect on the rate of nosocomial S. aureus infection, due to the poor efficacy of this type of treatment [19-21].
###end p 28
###begin p 29
###xml 61 70 61 70 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 133 142 133 142 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 378 387 378 387 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 483 492 483 492 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 61 70 <span type="species:ncbi:1280">S. aureus</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 133 142 <span type="species:ncbi:1280">S. aureus</span>
###xml 378 387 <span type="species:ncbi:1280">S. aureus</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 483 492 <span type="species:ncbi:1280">S. aureus</span>
The present study investigates the survival of two different S. aureus strains in a novel human nasal colonization model. We used an S. aureus strain (8325-4) expressing ClfB and its isogenic knockout, deficient in ClfB (DU5997). It was hypothesized that ClfB is essential for adherence to the nasal mucosa, hence absence of this factor would lead to a significant reduction in S. aureus survival in the human nose. Furthermore, we performed in vitro testing to demonstrate that the S. aureus cells growing under in vivo-like conditions can express ClfB and that these bacteria adhere to immobilized CK10.
###end p 29
###begin title 30
Materials and Methods
###end title 30
###begin title 31
Study Population
###end title 31
###begin p 32
###xml 148 160 <span type="species:ncbi:9606">participants</span>
###xml 577 589 <span type="species:ncbi:9606">Participants</span>
Sixteen healthy volunteers (six males and ten females, median age 32 y [range 19-51 y]) were included in this study. Prior to enrollment, potential participants received a medical checkup. Volunteers with a medical history of diabetes mellitus, renal insufficiency, chronic skin disease (eczema or psoriasis), chronic obstructive lung disease, disease of the heart valve, immune deficiency, or recent antibiotic use were excluded. Volunteers in close contact with individuals suffering from the afflictions mentioned above were excluded as well. Informed consent was obtained. Participants were notified of the fact that a dedicated infectious disease physician would be on call for the entire study period.
###end p 32
###begin title 33
Ethical Clearance
###end title 33
###begin p 34
###xml 164 173 164 173 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 164 173 <span type="species:ncbi:1280">S. aureus</span>
The study protocol was approved by the Medical Ethical Committee of Erasmus MC (MEC 156.137/1996/186). Permission to inoculate volunteers with genetically modified S. aureus strains was obtained from the Dutch authorities (Dutch Committee on Genetic Modification [COGEM] protocols BGGO 03/02.13 and CGM/040224-04).
###end p 34
###begin title 35
###xml 0 9 0 9 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
S. aureus Strains
###end title 35
###begin p 36
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b022">22</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b023">23</xref>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 541 550 541 550 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tetK</italic>
###xml 650 654 650 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">clfB</italic>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b024">24</xref>
###xml 752 761 752 761 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b025">25</xref>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 505 511 <span type="species:ncbi:9606">humans</span>
###xml 541 550 <span type="species:ncbi:1280">S. aureus</span>
###xml 752 761 <span type="species:ncbi:1280">S. aureus</span>
Strains 8325-4 (wild-type) and DU5997 (mutant) were used for artificial nasal colonization of the human volunteers. The genome sequence of the original 8325 strain is available at . The 8325-4 strain differs from 8325 by the absence of three prophages [22]; 8325-4 has a defect in the stationary-phase sigma factor (SigB) [23]. This strain is therefore unlikely to colonize and persist as well as 8325-4 wild-type strain (WT) or DU5997 (mutant strain) and thus facilitated a safe inoculation protocol for humans. DU5997 is a ClfB- mutant of S. aureus 8325-4 with a promoter-less tetK gene (encoding low-level tetracycline resistance) inserted in the clfB gene, as described previously [24]. For comparative growth experiments, we additionally used the S. aureus strain SH1000, a derivative of strain 8325-4, which expresses wild-type levels of SigB [25].
###end p 36
###begin title 37
Growth Experiment
###end title 37
###begin p 38
###xml 242 245 242 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
To reflect the in vivo situation, bacterial strains were grown in RPMI 1640 (Sigma), a minimal medium which is limited in iron. Strains were also grown in tryptic soy broth (TSB). Starter cultures were diluted in 60 ml of RPMI or TSB to an OD600 of 0.1 and grown at 37 degreesC with shaking (200 rpm) and absorbance at 600 nm monitored for 32 h (RPMI) or 24 h (TSB) using a spectrophotometer.
###end p 38
###begin title 39
Study Design: Artificial Inoculation Protocol
###end title 39
###begin p 40
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b026">26</xref>
###xml 317 327 317 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus.</italic>
###xml 473 481 473 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g001">Figure 1</xref>
###xml 317 326 <span type="species:ncbi:1280">S. aureus</span>
From all enrolled volunteers, we obtained two nasal cultures 1 wk apart before artificial inoculation in order to differentiate between persistent, intermittent, and non-carriers, as described previously (Nouwen et al. [26]). To be classified as a persistent carrier, both nasal cultures needed to be positive with a S. aureus.. In case of one positive culture, the volunteer was classified as an intermittent carrier. For non-carriers, all cultures needed to be negative. Figure 1 illustrates the design of the study. Decolonization treatment was started for all volunteers (nasal mupirocin twice daily for 5 d in combination with once-daily washing with chlorhexidine-containing soap for 5 d [Hibiscrub; Regent Medical]). Five weeks after mupirocin and chlorhexidine treatment, nostrils were cultured again to assess colonization status, and experimental nasal inoculation was performed.
###end p 40
###begin title 41
Study Design
###end title 41
###begin p 42
First, the left or right nostril was randomized to receive the inoculation mix, containing strains 8325-4 (WT) and DU5997 (mutant strain). Second, the contralateral nostril was randomized to receive either the naturally occurring ("WT" in figure) or mutant strain.
###end p 42
###begin p 43
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
The two inoculation strains, 8325-4 and DU5997 (ClfB-), were cultured separately to log phase in TSB. A mixture was prepared immediately prior to inoculation. In one nostril, 2 x 107 cfu of the 8325-4/DU5997 mixture in a 1:1 ratio was applied, whereas in the contralateral nostril, 1 x 107 cfu of either the 8325-4 or the DU5997 were installed. The nostrils of volunteers were randomized as follows: first, the left or right nostril was randomized to receive the inoculation mix by drawing a sealed envelope. Second, another envelope was drawn that contained instructions as to which single strain (8325-4 or DU5997) should be inoculated in the contralateral nostril. Thus, all 16 subjects had one nostril inoculated with the mixed culture, and half had the contralateral nostril inoculated with 8325-4 and the other half with DU5997. Randomization was stratified by carriage status.
###end p 43
###begin p 44
###xml 332 340 332 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g001">Figure 1</xref>
This design allowed for the assessment of the survival of both strains, depending on two different inoculation protocols. The inoculation was performed in a blinded fashion to prevent bias in reading the growth results of the nasal cultures. Follow-up cultures were performed on day 1, 2, 3, 4, 7, 14, 21, and 28 after inoculation (Figure 1).
###end p 44
###begin title 45
SDS-PAGE, Western Immunoblotting, and Zymography
###end title 45
###begin p 46
###xml 0 9 0 9 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 39 42 39 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 353 354 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
###xml 1014 1025 <span type="species:ncbi:3704">horseradish</span>
S. aureus cells were suspended to an OD600 of 40 in 30% raffinose plus 20 mM MgCl2 in a final volume of 100 mul. To each sample, 12-mul lysostaphin (2 mg/ml) and 8-mul protease inhibitors (Complete cocktail; Boehringer Mannheim) were added, and the suspension was incubated at 37 degreesC for 20 min. Protoplasts were removed by centrifugation at 12,000g for 10 min. Supernatants containing wall-associated proteins were boiled for 5 min in an equal volume of final sample buffer (0.125 M Tris-HCl [pH 6.8], 4% [w/v] SDS, 20% [v/v] glycerol, 10% [v/v] beta-mercaptoethanol, and 0.002% [w/v] bromophenol blue). SDS-PAGE was performed by standard methods. Proteins were electrophoretically transferred to PVDF Western blotting membranes (Boehringer Mannheim) by the wet system (Bio-Rad). Membranes were incubated overnight at 4 degreesC in 10% blocking reagent (Marvel milk powder). Primary anti-ClfB A region antibody was used at a dilution of 1:5,000 for a 1-h incubation at room temperature. Protein A-conjugated horseradish peroxidase (Sigma, a 1 mg/ml stock diluted 1:500) was used to detect bound antibody by incubation for 1 h at room temperature. Membranes were developed using LumiGLO chemiluminescent substrate (New England BioLabs), according to manufacturer's instructions and exposed to X-ray film.
###end p 46
###begin title 47
###xml 56 61 <span type="species:ncbi:9606">Human</span>
Adherence of Bacterial Cells to Immobilized Recombinant Human Cytokeratin 10
###end title 47
###begin p 48
###xml 13 22 13 22 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 213 214 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 436 439 424 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 13 22 <span type="species:ncbi:1280">S. aureus</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 264 270 <span type="species:ncbi:9913">Bovine</span>
Adherence of S. aureus to immobilized recombinant human cytokeratin 10 (rMK10) was performed as follows. Nunc-Immuno MaxiSorb microtitre plates were coated with rMK10 in carbonate buffer (15 mM Na2CO3, 35 mM NaHCO3 [pH 9.6]) and incubated overnight at 4 degreesC. Bovine serum albumin (5 mg/ml) was added, and the plates were incubated for 2 h at 37 degreesC. The plates were washed three times with PBS. A bacterial cell suspension (OD600 = 1.0 in PBS) was added (100 mul/well), and the plates were incubated for 1.5 h at 37 degreesC. Plates were washed three times with PBS; bound cells were fixed with formaldehyde (25% v/v) for 30 min and then stained with Crystal Violet (0.5% v/v, 100 mul/well) for 1 min. After three washes with PBS, acetic acid (5% v/v) was added (100 mul/well), and cells were incubated for 10 min at room temperature. The absorbance was measured at 570 nm in an ELISA plate reader (Labsystems Multiskan Plus).
###end p 48
###begin title 49
Microbiological Procedures
###end title 49
###begin p 50
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b018">18</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b026">26</xref>
###xml 459 468 459 468 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 612 621 612 621 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 691 700 691 700 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 43 49 <span type="species:ncbi:3635">cotton</span>
###xml 459 468 <span type="species:ncbi:1280">S. aureus</span>
###xml 612 621 <span type="species:ncbi:1280">S. aureus</span>
###xml 667 678 <span type="species:ncbi:9606">participant</span>
###xml 691 700 <span type="species:ncbi:1280">S. aureus</span>
Nasal specimens were obtained with sterile cotton swabs (Tran swab; Medical Wire & Equipment) from each nostril separately. Swabs were processed immediately by vortexing vigorously in Stuart's medium. Dilutions of this medium were inoculated on phenol red-mannitol salt agar (PHMA) and in phenol red-mannitol salt broth (PHMB) according to previously published protocols for quantitative carriage assessment [18,26]. All positive postinoculation cultures for S. aureus were screened for tetracycline resistance, by plating on media with and without tetracycline, to assess the presence of tetracycline-resistant S. aureus strains in the endogenous nasal flora of the participant. The DU5997 S. aureus strain has low-level tetracycline resistance (minimal inhibitory concentration: 2 mug/ml). Technicians reading the agar plates were unaware what strains were inoculated in the volunteers (blinded assessment).
###end p 50
###begin title 51
Bacterial Genotyping
###end title 51
###begin p 52
###xml 888 890 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b027">27</xref>
Testing for tetracycline resistance was performed by disk diffusion. Resistance was verified by PCR with specific primers spanning the insertion site of the tetracycline resistance cassette. Furthermore, two random isolates per culture (either resistant or sensitive to tetracycline) were genotyped by pulsed-field gel electrophoresis (PFGE) (CHEF Mapper; Biorad). DNA within the plugs was digested using 20 U SmaI (Roche Molecular Diagnostics) during 4 h at 25 degreesC in SuRe-cut buffer. The electrophoresis protocol was performed at 6 V/cm and 14 degreesC using 0.5x TBE buffer (Biorad). The program consisted of two blocks: 10 h at 60degrees/-60degrees angles with a switch time of 5-15 s, followed by 10 h at 60degrees/-60degrees angles and a switch time of 15-45 s. Strains were considered to be clonally related if their PFGE fingerprints did not differ by more than three bands [27].
###end p 52
###begin title 53
Anti-ClfB ELISA
###end title 53
###begin p 54
###xml 792 793 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 795 796 782 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 334 340 <span type="species:ncbi:9913">bovine</span>
###xml 538 549 <span type="species:ncbi:3704">horseradish</span>
###xml 575 581 <span type="species:ncbi:9986">rabbit</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
The working volume of serum for the ELISA was 100 mul. After each step, the microplates were washed three times with phosphate-buffered saline (PBS; pH 7.4) containing 0.1% v/v Tween 20. The microplates were coated with recombinant ClfB in 50 mM sodium carbonate (pH 9.5) overnight at 4 degreesC. Blocking was performed with 5% (w/v) bovine serum albumin in PBS for 2 h at 37 degreesC and washing for three times with PBS. Serum of the volunteers was then applied and incubated for 1 h at room temperature with shaking. Dilute (1:10,000) horseradish peroxidase conjugated to rabbit anti-human antibodies (Dako) was then added to the wells, and the incubation was continued for 1 h at room temperature. The reaction was developed by the addition of tetramethylbenzidine and stopped by adding H2SO4. The reaction was measured at 450 nm in an ELISA plate reader (Bio-Rad).
###end p 54
###begin title 55
Sample-Size Calculation
###end title 55
###begin p 56
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b018">18</xref>
An earlier inoculation study showed that after artificial inoculation, more than half of those inoculated still carried the inoculating strain at 1-mo follow-up [18]. We estimated that at the end of follow-up, the 8325-4 strain would still be present in 50% of the inoculated volunteers, and the DU5997 strain in 10%. With a confidence level of 95% and a power of 80%, we would need to inoculate both the 8325-4 strain and the DU5997 strain in at least 15 healthy volunteers.
###end p 56
###begin title 57
Statistics
###end title 57
###begin p 58
###xml 256 265 256 265 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 368 377 368 377 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 506 507 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 650 659 650 659 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 256 265 <span type="species:ncbi:1280">S. aureus</span>
###xml 368 377 <span type="species:ncbi:1280">S. aureus</span>
###xml 650 659 <span type="species:ncbi:1280">S. aureus</span>
The primary outcome measurement was the survival time of both the 8325-4 and DU5997 strain per individual, and analyzed by Kaplan-Meier survival analysis (log-rank test). The survival time was defined as the number of days until the last positive culture. S. aureus strains still present at the end of follow-up were censored. The mean numbers of 8325-4 versus DU5997 S. aureus cfu were compared by two-way ANOVA, after log transformation of the number of cfu. Other comparisons of means were performed by t-test, Mann-Whitney U test, or one-way ANOVA, where appropriate. Nonparametric correlations were estimated for ClfB antibody titer and time to S. aureus clearance from the nose. p-Values, two-tailed, below 0.05 were considered statistically significant. All statistical analyses were performed with SPSS 11.5 for Windows software (SPSS). Means and medians are given with their standard deviations or interquartile range.
###end p 58
###begin title 59
Results
###end title 59
###begin title 60
Nasal Carriage Status before Inoculation
###end title 60
###begin p 61
###xml 381 389 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g001">Figure 1</xref>
###xml 436 445 436 445 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 547 556 547 556 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 436 445 <span type="species:ncbi:1280">S. aureus</span>
###xml 547 556 <span type="species:ncbi:1280">S. aureus</span>
None of the volunteers included in the present study encountered adverse effects, and all adhered to the study protocol for the duration of the experiment. At the start of the protocol, the carriage status was assessed: there were six persistent carriers, two intermittent carriers, and eight non-carriers. All volunteers received mupirocin nasal ointment 5 wk before inoculation (Figure 1). Five volunteers still carried low levels of S. aureus in their noses after mupirocin treatment, just before inoculation (median: 1 cfu/ml). The endogenous S. aureus strains of the volunteers who were carriers had distinct PFGE fingerprints compared to the test strains (unpublished data).
###end p 61
###begin title 62
The DU5997 Strain Has the Same Fitness as the 8325-4 Strain
###end title 62
###begin p 63
###xml 575 583 575 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g002">Figure 2</xref>
We compared the growth of strain 8325-4 with SH1000 (which has a fully functional SigB), and with DU5997 (which is defective in ClfB). Growth was carried out in a medium reflective of growth conditions in vivo. The results show that bacteria grew more slowly and to a much lower optical density in stationary phase in RPMI as compared to TSB. Doubling times for 8325-4 were 108 min in RPMI and 40 min in TSB. In RPMI, the growth rates and yields of 8325-4 and DU5997 were indistinguishable, whereas SH1000 grew slightly faster (doubling time 96 min) and to a higher density (Figure 2A).
###end p 63
###begin title 64
ClfB Expression Experiments
###end title 64
###begin p 65
(A) Bacterial growth and ClfB expression in RPMI. Strains 8325-4, DU5997, and SH1000 were grown in RPMI, and samples were taken at regular intervals to monitor growth.
###end p 65
###begin p 66
(B) Samples taken at early exponential, early stationary, and late stationary phases of growth were analyzed by Western immunoblotting. Lanes 1, 2, and 3 show ClfB expression from strain 8325-4 at early exponential, early stationary, and late stationary growth phases, respectively. Lanes 4, 5, and 6 show ClfB expression from strain DU5997 at early exponential, early stationary, and late stationary growth phases, respectively. Lanes 7, 8, and 9 show ClfB expression from SH1000 at early exponential, early stationary, and late stationary growth phases, respectively.
###end p 66
###begin p 67
(C) Bacterial growth and ClfB expression in TSB. Strain 8325-4 was grown in TSB, and samples were taken at regular intervals to monitor growth.
###end p 67
###begin p 68
(D) Western immunoblotting was carried out to detect ClfB expression at early exponential, early stationary, and late stationary phases of growth. Lanes 1, 2, and 3 show ClfB expression from strain 8325-4 grown in TSB at early exponential, early stationary, and late stationary growth phases, respectively.
###end p 68
###begin title 69
ClfB Expression-Dependent Adherence to Cytokeratin 10
###end title 69
###begin p 70
###xml 223 231 223 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g002">Figure 2</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b028">28</xref>
###xml 389 397 389 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g002">Figure 2</xref>
Expression of ClfB by RPMI- and TSB-grown bacteria was compared. Previously, it was shown that ClfB protein was not detectable on 8325-4 cells from the stationary phase of growth in rich media, and this was confirmed here (Figure 2B) [28]. In contrast, intact ClfB was present at the same level in RPMI-grown SH1000 and 8325-4 during all phases of growth, including late stationary phase (Figure 2B).
###end p 70
###begin p 71
###xml 108 116 108 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g003">Figure 3</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b028">28</xref>
Bacterial cells grown to mid-exponential phase were tested for their ability to adhere to immobilized CK10 (Figure 3). Strain 8325-4 grown in TSB adhered more strongly to CK10 than 8325-4 grown in RPMI, despite degradation of some ClfB molecules to the nonfunctional form lacking domain N1 [28]. DU5997, which is completely defective in ClfB expression, adhered poorly, indicating that the adherence of RPMI-grown bacteria to CK10 is dependent on the presence of ClfB.
###end p 71
###begin title 72
###xml 0 9 0 9 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
S. aureus Adherence to Recombinant Cytokeratin 10 in Different Growth Stages
###end title 72
###begin p 73
Data are epresentative of three independent experiments. Bars represent standard deviation.
###end p 73
###begin p 74
(A) Adherence of bacterial cells in exponential phase of growth to rMK10. Strain 8325-4 was grown to exponential phase in RPMI or TSB, and its ability to bind rMK10 was compared to DU5997 grown in RPMI.
###end p 74
###begin p 75
(B) Adherence of bacterial cells in stationary phase of growth to rMK10. Strain 8325-4 was grown to stationary phase in RPMI or TSB, and its ability to bind rMK10 was compared to DU5997 grown in RPMI.
###end p 75
###begin p 76
###xml 108 116 108 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g003">Figure 3</xref>
###xml 170 178 170 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g002">Figure 2</xref>
In contrast to exponential phase cells, 8325-4 grown to stationary phase in TSB was defective in adherence (Figure 3), which is consistent with the lack of ClfB shown in Figure 2D. Strain 8325-4 grown to stationary phase in RPMI adhered more strongly to CK10 than the equivalent number of cells from exponential phase, whereas the DU5997 bound poorly.
###end p 76
###begin title 77
Strain 8325-4 Persists in the Nose, DU5997 Does Not
###end title 77
###begin p 78
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
Upon inoculation of 8325-4 and DU5997 ClfB- cells, the majority of the volunteers (14/16) did not harbor the DU5997 strain after day 4, whereas fewer volunteers (7/16) lacked the 8325-4 strain after this stage. After 2 wk, all volunteers had eliminated the DU5997 strain, whereas the 8325-4 strain was still present in three volunteers after 28 d, at the end of follow-up. These three volunteers were found to be persistent or intermittent nasal carriers during the preinoculation screening.
###end p 78
###begin p 79
###xml 256 257 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 267 275 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g004">Figure 4</xref>
###xml 300 309 296 305 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 370 378 366 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g004">Figure 4</xref>
###xml 416 425 412 421 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 614 615 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 821 825 811 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">clfB</italic>
###xml 300 309 <span type="species:ncbi:1280">S. aureus</span>
###xml 416 425 <span type="species:ncbi:1280">S. aureus</span>
The overall median survival time of the 8325-4 strain was significantly higher than the DU5997 strain: a median of 7.0 (95% confidence interval [CI], +/-4 d; interquartile range: 2-21 d) compared to 3 (95% CI, +/-1 d; interquartile range: 2-4 d; log-rank: p = 0.006; Figure 4A). The viable counts of S. aureus after inoculation were always higher for the 8325-4 strain (Figure 4C), but not significantly. Inoculated S. aureus cells could be cultured for a longer mean follow-up period from intermittent carriers (18.3 +/- 12.1 d) than from persistent (7.0 +/- 8.6 d) or non-carriers (5.4 +/- 6.3 d; one-way ANOVA: p = 0.025). None of the volunteers used antibiotics during the follow-up period. Identification of the inoculation strains was confirmed by tetracycline susceptibility testing, PFGE, and PCR analysis of the clfB locus.
###end p 79
###begin title 80
Survival in the Nose of the Wild-Type Strain versus the Mutant Strain
###end title 80
###begin p 81
###xml 46 55 46 55 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 318 327 318 327 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 46 55 <span type="species:ncbi:1280">S. aureus</span>
###xml 123 128 <span type="species:ncbi:9606">human</span>
###xml 318 327 <span type="species:ncbi:1280">S. aureus</span>
(A) Kaplan-Meier survival curve of the 8325-4 S. aureus (solid line) and its ClfB- mutant (DU5997) strain (dashed line) in human nose (last cultured strain in either nostril). All cells of the mutant strain were eliminated after a period of 14 d, which is significantly faster than the elimination rate for the 8325-4 S. aureus strain.
###end p 81
###begin p 82
###xml 46 55 46 55 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 46 55 <span type="species:ncbi:1280">S. aureus</span>
(B) Kaplan-Meier survival curve of the 8325-4 S. aureus (WT) and ClfB- mutant (DU5997; dashed line) that were inoculated together as a mix in one nostril.
###end p 82
###begin p 83
(C) Number of cfu of 8325-4 and DU5997 in follow-up samples.
###end p 83
###begin p 84
###xml 272 273 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 283 291 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050017-g004">Figure 4</xref>
Analyzing the survival within the nostril in which the mix was inoculated also shows that the 8325-4 strain survives significantly longer: a median of 4.0 (95% CI, +/- 1 d; interquartile range: 2-7 d) compared to 3.0 (95% CI, +/-1 d; interquartile range: 1-3 d; log rank: p = 0.033; Figure 4B). Comparing the survival of the 8325-4 strain inoculated singularly in eight nostrils versus the DU5997 strain inoculated in eight other volunteers, also showed a longer survival for 8325-4, but this did not reach statistical significance (unpublished data). In this experiment, we also evaluated whether strains crossed over to the contralateral nostril, irrespective of bacterial load and strain displacement. In two instances, there was crossover from the DU5997 strain from the mix to the contralateral nostril where only 8325-4 strain was inoculated (only on the first day after artificial inoculation). The 8325-4 strain from the mix crossed over in six volunteers to the contralateral nostril where only the DU5997 was inoculated, occurring as of day 1 up to day 28 of follow-up.
###end p 84
###begin title 85
Dynamics in ClfB Antibody Response
###end title 85
###begin p 86
###xml 267 276 267 276 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 402 403 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 405 406 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 565 574 561 570 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 621 622 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 624 625 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 740 749 732 741 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 267 276 <span type="species:ncbi:1280">S. aureus</span>
###xml 565 574 <span type="species:ncbi:1280">S. aureus</span>
###xml 740 749 <span type="species:ncbi:1280">S. aureus</span>
To assess the role of the anti-ClfB antibody response in the survival of the inoculating strains, we performed anti-ClfB ELISA. The anti-ClfB antibody levels in volunteers did not change during the 4 wk following inoculation. However, volunteers who were carriers of S. aureus had a higher anti-ClfB antibody level: 2.0 +/- 0.7 (extinction), than those who were non-carriers: 1.3 +/- 0.7 (Mann-Whitney U: p = 0.093). Those volunteers who were still carrying the 8325-4 strain after 28 d also had a higher anti-ClfB antibody titer compared to those who were free of S. aureus: 2.4 +/- 0.4 versus 1.5 +/- 0.7 (Mann-Whitney U: p = 0.069). Finally, there was no correlation between the anti-ClfB antibody titer and the time needed to eradicate S. aureus from the nose (unpublished data).
###end p 86
###begin title 87
Discussion
###end title 87
###begin p 88
###xml 105 114 105 114 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 278 287 278 287 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 105 114 <span type="species:ncbi:1280">S. aureus</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 278 287 <span type="species:ncbi:1280">S. aureus</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
We report here the first study, to our knowledge, of healthy human volunteers being coinoculated with an S. aureus 8325-4 strain and an isogenic mutant defective in the MSCRAMM ClfB (DU5997). We show that ClfB is an important factor for establishing human nasal colonization by S. aureus, as the ClfB- mutant (DU5997) was not able to survive in the human nose after 2 wk. In contrast, the 8325-4 strain was still present at the end of follow-up in three volunteers.
###end p 88
###begin p 89
Because we performed two different inoculation protocols within each volunteer, crossover of strains to the contralateral nostril complicated the analysis of this study. The 8325-4 strain from the mix crossed over in six volunteers, whereas the DU5997 strain only crossed over in two instances. Furthermore, the 8325-4 strain showed this phenomenon up to the last day of follow-up. The DU5997 only crossed over on the first day of follow up and never after. These findings highlight the complexity of interpretation of in vivo studies but strongly suggest that 8325-4 is better able to colonize than DU5997.
###end p 89
###begin p 90
###xml 319 328 319 328 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b018">18</xref>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 319 328 <span type="species:ncbi:1280">S. aureus</span>
###xml 560 566 <span type="species:ncbi:9606">humans</span>
The results of our study regarding the number of volunteers still colonized after 1 mo are different than the assumptions of our sample-size calculation. At the end of follow-up, only 19% of the volunteers carried the 8325-4 strain, not 50%. This low carriage may be due to the fact that we inoculated only one type of S. aureus strain and not a mix with different clones as performed by Nouwen et al. [18]. In addition, the 8325-4 strain has been propagated in the laboratory for a long period and might have lost most of its capacity to effectively colonize humans. On the other hand, the survival of the ClfB- mutant (DU5997) was lower than estimated (0% at day 28, instead of 10%), illustrating the crucial role of ClfB in adherence to the nasal mucosa.
###end p 90
###begin p 91
###xml 247 256 247 256 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">clfB</italic>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b010">10</xref>
###xml 470 471 470 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 247 256 <span type="species:ncbi:1280">S. aureus</span>
###xml 399 404 <span type="species:ncbi:9606">human</span>
Interestingly, 8325-4 grown to stationary phase in a nutrient-deficient medium, comparable to that of the nasal niche, adhered to rK10, whereas the same strain grown in a rich medium did not. Thus, it seems plausible that ClfB is expressed in all S. aureus growth stages in the nose, a relatively nutrient-deficient environment. Expression of the clfB gene directly in the growth environment of the human nose has been demonstrated previously [10]. Furthermore, the ClfB- mutant grown in nutrient-deficient media was unable to adhere to immobilized CK10. These in vitro study results support our in vivo findings.
###end p 91
###begin p 92
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b010">10</xref>
###xml 260 269 260 269 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b015">15</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b029">29</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b030">30</xref>
###xml 528 537 528 537 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 690 699 690 699 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 260 269 <span type="species:ncbi:1280">S. aureus</span>
###xml 528 537 <span type="species:ncbi:1280">S. aureus</span>
###xml 690 699 <span type="species:ncbi:1280">S. aureus</span>
###xml 734 739 <span type="species:ncbi:9606">human</span>
###xml 804 809 <span type="species:ncbi:9606">human</span>
Other in vitro studies showed ClfB-deficient mutants could still adhere to nasal epithelial cells [10]. Even though these experiments were not performed in nutrient-deficient media, it is unlikely that ClfB is the sole determinant of nasal colonization. Other S. aureus surface factors, including capsular polysaccharides, teichoic acid, and iron-responsive surface determinant protein (IsdA), also promote adherence to the nasal mucosal surfaces [15,29,30]. These studies were performed either in vitro or in animals. Clearly, S. aureus adherence to and colonization of the epithelium in the nares is complex and multifactorial. Only the direct application of viable, genetically modified S. aureus cells in their natural niche, the human vestibulum nasi, will allow functional characterization of both human and microbial factors required for colonization.
###end p 92
###begin p 93
###xml 398 407 398 407 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b031">31</xref>
###xml 567 576 567 576 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 398 407 <span type="species:ncbi:1280">S. aureus</span>
###xml 567 576 <span type="species:ncbi:1280">S. aureus</span>
Regarding the complexity of the human factor: in this study. the anti-ClfB antibody response was also assessed. No rise in the anti-ClfB response after the artificial colonization was documented. This may be explained by the fact that 8325-4 has a defect in the stationary phase SigB and is therefore considered less virulent, and may therefore be less "immunogenic." We did find that, in general, S. aureus carriers had higher anti-ClfB levels than non-carriers. This is concordant with the results of Dryla et al. [31], who found significantly higher IgG levels in S. aureus nasal carriers.
###end p 93
###begin p 94
###xml 26 35 26 35 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b006">6</xref>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050017-b007">7</xref>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ClfB<sup>&#8722;</sup></italic>
###xml 416 425 416 425 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 26 35 <span type="species:ncbi:1280">S. aureus</span>
###xml 123 128 <span type="species:ncbi:9606">human</span>
###xml 352 357 <span type="species:ncbi:9606">human</span>
###xml 416 425 <span type="species:ncbi:1280">S. aureus</span>
Effective intervention in S. aureus colonization for the prevention of subsequent infection requires the identification of human and bacterial factors important in establishing nasal colonization [6,7]. This study of a 8325-4 strain and an isogenic ClfB- null mutant revealed the relevance of the staphylococcal adhesin ClfB in the colonization of the human nose and demonstrates that ClfB is a potential target for S. aureus decolonization strategies.
###end p 94
###begin title 95
Limitations of This Study
###end title 95
###begin p 96
###xml 240 249 240 249 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 395 404 395 404 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 240 249 <span type="species:ncbi:1280">S. aureus</span>
###xml 342 348 <span type="species:ncbi:9606">humans</span>
###xml 395 404 <span type="species:ncbi:1280">S. aureus</span>
A limitation of this study was the use of the 8325-4 strain. As mentioned before, this strain has a defect in the stationary phase SigB and is therefore unlikely to colonize and persist as well as wild-type strains we would find in natural S. aureus nasal carriers. We chose this strain because it facilitated a safe inoculation protocol for humans and actually made this experiment possible. A S. aureus strain from a natural carrier with no major virulence factors, such as superantigens, would be preferred for future artificial inoculation experiments.
###end p 96
###begin p 97
We would like to thank Nicole Lemmens, who performed elegant ClfB expression analysis experiments with quantitative mRNA PCR techniques, but her data were eventually not used in the final version of this manuscript. Both Heiman F. L. Wertheim and Alex van Belkum had full access to the data and take full responsibility for the integrity of the data and the accuracy of the data analysis.
###end p 97
###begin title 98
Abbreviations
###end title 98
###begin p 99
colony-forming unit
###end p 99
###begin p 100
confidence interval
###end p 100
###begin p 101
cytokeratin 10
###end p 101
###begin p 102
clumping factor B
###end p 102
###begin p 103
microbial surface components recognizing adhesive matrix molecule
###end p 103
###begin p 104
phosphate-buffered saline
###end p 104
###begin p 105
pulsed-field gel electrophoresis
###end p 105
###begin p 106
sigma factor
###end p 106
###begin p 107
tryptic soy broth
###end p 107
###begin title 108
References
###end title 108
###begin article-title 109
###xml 62 83 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus-and their relation to community-associated disease activity
###end article-title 109
###begin article-title 110
###xml 22 31 <span type="species:ncbi:1280">S. aureus</span>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Methicillin-resistant S. aureus infections among patients in the emergency department
###end article-title 110
###begin article-title 111
###xml 30 51 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group
###end article-title 111
###begin article-title 112
###xml 31 52 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers
###end article-title 112
###begin article-title 113
###xml 30 51 <span type="species:ncbi:1280">Staphylococcus aureus</span>
The role of nasal carriage in Staphylococcus aureus infections
###end article-title 113
###begin article-title 114
###xml 81 102 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice
###end article-title 114
###begin article-title 115
###xml 47 68 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Host- and tissue-specific pathogenic traits of Staphylococcus aureus
###end article-title 115
###begin article-title 116
MSCRAMM-mediated adherence of microorganisms to host tissues
###end article-title 116
###begin article-title 117
###xml 84 110 <span type="species:ncbi:1334">Streptococcus dysgalactiae</span>
A monoclonal antibody enhances ligand binding of fibronectin MSCRAMM (adhesin) from Streptococcus dysgalactiae
###end article-title 117
###begin article-title 118
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization
###end article-title 118
###begin article-title 119
###xml 128 149 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10
###end article-title 119
###begin article-title 120
The cornified envelope: a model of cell death in the skin
###end article-title 120
###begin article-title 121
###xml 18 39 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 130 136 <span type="species:ncbi:10090">murine</span>
Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model
###end article-title 121
###begin article-title 122
###xml 38 59 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Development and characterization of a Staphylococcus aureus nasal colonization model in mice
###end article-title 122
###begin article-title 123
###xml 26 47 26 47 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 26 47 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections
###end article-title 123
###begin article-title 124
###xml 66 87 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus
###end article-title 124
###begin article-title 125
###xml 14 35 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Attachment of Staphylococcus aureus to eukaryotic cells and experimental pitfalls in staphylococcal adherence assays: a critical appraisal
###end article-title 125
###begin article-title 126
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 16 37 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Human factor in Staphylococcus aureus nasal carriage
###end article-title 126
###begin article-title 127
Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study
###end article-title 127
###begin article-title 128
###xml 46 67 46 67 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 46 67 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections
###end article-title 128
###begin article-title 129
###xml 41 62 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study
###end article-title 129
###begin article-title 130
###xml 60 81 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus
###end article-title 130
###begin article-title 131
###xml 37 58 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Sigma(B) activity depends on RsbU in Staphylococcus aureus
###end article-title 131
###begin article-title 132
###xml 29 50 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Analysis of mutations in the Staphylococcus aureus clfB promoter leading to increased expression
###end article-title 132
###begin article-title 133
###xml 131 152 <span type="species:ncbi:1280">Staphylococcus aureus</span>
sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4
###end article-title 133
###begin article-title 134
###xml 15 36 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule."
###end article-title 134
###begin article-title 135
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing
###end article-title 135
###begin article-title 136
###xml 57 78 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease
###end article-title 136
###begin article-title 137
###xml 13 34 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase
###end article-title 137
###begin article-title 138
###xml 8 29 <span type="species:ncbi:1280">Staphylococcus aureus</span>
IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin
###end article-title 138
###begin article-title 139
###xml 43 64 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients
###end article-title 139
###begin p 140
###xml 0 8 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#164;</sup>
currencyCurrent address: Oxford University Clinical Research Unit, National Institute of Infectious and Tropical Diseases, Hanoi, Vietnam
###end p 140
###begin p 141
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. HFLW, DCM, HAV, TF, and AvB wrote the protocol. HFLW, EW, HAMB, and HM performed data analysis. HFLW, DCM, HAV, and AvB interpreted the data. EW, RC, HAMB, and HM performed the experiments. HFLW, TF, and AvB supervised the experiments. RC and DCM enrolled volunteers. HFLW and AvB wrote the paper. EW, RC, DCM, HM, HAV, and TF gave final approval to the manuscript.
###end p 141
###begin p 142
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This research was made possible by research grants provided by the Erasmus Trustfund (97030.14/04.0687/pme), Science Foundation Ireland (03/IN3/B70), and The Wellcome Trust (0728220). These funding agencies had no involvement in the study design, data collection, data analysis, data interpretation, deciding to publish, or writing of these report.
###end p 142
###begin p 143
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 143

